Partner

Marc Moens

Causaly

Causaly is developing AI and machine learning technology for biomedical cause and effect discovery, which allows researchers and decision makers in Pharma and Life Sciences to quickly find causal evidence.

HQ

London

Key People

Yiannis Kiachopoulos (CEO)

Artur Saudabayev (CTO)

Co-investors

EBRD

Marathon Venture Capital